These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 1331290)

  • 21. The C domain in the surface envelope glycoprotein of subgroup C feline leukemia virus is a second receptor-binding domain.
    Rey MA; Prasad R; Tailor CS
    Virology; 2008 Jan; 370(2):273-84. PubMed ID: 17945326
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of a feline leukemia virus variant that can use THTR1, FLVCR1, and FLVCR2 for infection.
    Shalev Z; Duffy SP; Adema KW; Prasad R; Hussain N; Willett BJ; Tailor CS
    J Virol; 2009 Jul; 83(13):6706-16. PubMed ID: 19369334
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic determinants of feline leukemia virus-induced multicentric lymphomas.
    Athas GB; Choi B; Prabhu S; Lobelle-Rich PA; Levy LS
    Virology; 1995 Dec; 214(2):431-8. PubMed ID: 8553544
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nucleotide sequences of a feline leukemia virus subgroup A envelope gene and long terminal repeat and evidence for the recombinational origin of subgroup B viruses.
    Stewart MA; Warnock M; Wheeler A; Wilkie N; Mullins JI; Onions DE; Neil JC
    J Virol; 1986 Jun; 58(3):825-34. PubMed ID: 3009890
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evolution of feline leukemia virus variant genomes with insertions, deletions, and defective envelope genes in infected cats with tumors.
    Rohn JL; Linenberger ML; Hoover EA; Overbaugh J
    J Virol; 1994 Apr; 68(4):2458-67. PubMed ID: 8139030
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biologically selected recombinants between feline leukemia virus (FeLV) subgroup A and an endogenous FeLV element.
    Sheets RL; Pandey R; Klement V; Grant CK; Roy-Burman P
    Virology; 1992 Oct; 190(2):849-55. PubMed ID: 1381539
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pathogenicity of a subgroup C feline leukemia virus (FeLV) is augmented when administered in association with certain FeLV recombinants.
    Mathes LE; Pandey R; Chakrabarti R; Hofman FM; Hayes KA; Stromberg P; Roy-Burman P
    Virology; 1994 Jan; 198(1):185-95. PubMed ID: 8259654
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pathogenic and host range determinants of the feline aplastic anemia retrovirus.
    Riedel N; Hoover EA; Dornsife RE; Mullins JI
    Proc Natl Acad Sci U S A; 1988 Apr; 85(8):2758-62. PubMed ID: 2833751
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Induction of feline leukaemia virus-neutralizing antibodies by immunization with synthetic peptides derived from the FeLV env gene.
    Weijer K; Pfauth A; van Herwijnen R; Jarrett O; Meloen RH; Tomee C; Osterhaus AD
    Vaccine; 1993; 11(9):946-56. PubMed ID: 7692683
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Naturally occurring feline leukemia virus subgroup A and B infections in urban domestic cats.
    Coelho FM; Bomfim MRQ; de Andrade Caxito F; Ribeiro NA; Luppi MM; Costa ÉA; Oliveira ME; Da Fonseca FG; Resende M
    J Gen Virol; 2008 Nov; 89(Pt 11):2799-2805. PubMed ID: 18931078
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Unique long terminal repeat and surface glycoprotein gene sequences of feline leukemia virus as determinants of disease outcome.
    Chandhasin C; Coan PN; Pandrea I; Grant CK; Lobelle-Rich PA; Puetter A; Levy LS
    J Virol; 2005 May; 79(9):5278-87. PubMed ID: 15827142
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pathogenicity induced by feline leukemia virus, Rickard strain, subgroup A plasmid DNA (pFRA).
    Chen H; Bechtel MK; Shi Y; Phipps A; Mathes LE; Hayes KA; Roy-Burman P
    J Virol; 1998 Sep; 72(9):7048-56. PubMed ID: 9696797
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Feline Leukemia Virus (FeLV) Endogenous and Exogenous Recombination Events Result in Multiple FeLV-B Subtypes during Natural Infection.
    Erbeck K; Gagne RB; Kraberger S; Chiu ES; Roelke-Parker M; VandeWoude S
    J Virol; 2021 Aug; 95(18):e0035321. PubMed ID: 34232703
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of feline leukemia virus subgroup A infection by coinoculation with subgroup B.
    Phipps AJ; Hayes KA; Al-dubaib M; Roy-Burman P; Mathes LE
    Virology; 2000 Nov; 277(1):40-7. PubMed ID: 11062034
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The host range and interference properties of two closely related feline leukemia variants suggest that they use distinct receptors.
    Moser M; Burns CC; Boomer S; Overbaugh J
    Virology; 1998 Mar; 242(2):366-77. PubMed ID: 9514965
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nucleotide sequence and distinctive characteristics of the env gene of endogenous feline leukemia provirus.
    Kumar DV; Berry BT; Roy-Burman P
    J Virol; 1989 May; 63(5):2379-84. PubMed ID: 2539525
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Host cell range of T-lymphotropic feline leukemia virus in vitro.
    Shojima T; Nakata R; Miyazawa T
    Biochem Biophys Res Commun; 2006 Jul; 345(4):1466-70. PubMed ID: 16730653
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vivo infection of marrow stromal fibroblasts by feline leukemia virus.
    Linenberger ML; Abkowitz JL
    Exp Hematol; 1992 Sep; 20(8):1022-7. PubMed ID: 1324184
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Variable regions A and B in the envelope glycoproteins of feline leukemia virus subgroup B and amphotropic murine leukemia virus interact with discrete receptor domains.
    Tailor CS; Kabat D
    J Virol; 1997 Dec; 71(12):9383-91. PubMed ID: 9371598
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vivo evolution of a novel, syncytium-inducing and cytopathic feline leukemia virus variant.
    Rohn JL; Moser MS; Gwynn SR; Baldwin DN; Overbaugh J
    J Virol; 1998 Apr; 72(4):2686-96. PubMed ID: 9525586
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.